Q4 2024 Earnings Call Transcript February 4, 2025 Operator: Hello, and welcome to Regeneron Pharmaceuticals Fourth Quarter 2024 Earnings Conference Call. My name is Tawanda, and I will be your ...

Several medicines are poised to reach new heights after winning key endorsements from European drug regulators. | Among those ...

On January 16, 2025, the Food and Drug Administration (FDA) issued an order banning FD&C Red No.3 in food and ingested drugs.1 Food and ingested ...

Cognitively normal human brain samples collected at autopsy in early 2024 contained more tiny shards of plastic than samples ...

The FDA said manufacturers who use red three in food and ingested drugs will have until January 15, 2027 or January 18, 2028, ...

Duato discusses the split of the business, dealing with the scrutiny brought about by lawsuits, and 2025 priorities.

You may have heard in the news that the U.S. Food and Drug Administration will no longer allow the use of FD&C Red Dye No. 3 ...

Another pharmaceutical product that was recently recalled due ... Requirements for Registration of Pharmaceuticals for Human Use (ICH) is working to facilitate international harmonization in ...

KELOWNA, BC / ACCESS Newswire / January 30, 2025 / Lexaria Bioscience Corp. (NASDAQ:LEXX)(NASDAQ:LEXXW), (the "Company" or "Lexaria"), a global innovator in drug delivery platforms is pleased to provi ...

The U.S. Food and Drug Administration’s recent ban on the use of a popular food dye will create a new challenge for home ...

Shakthi Kumar, EDETEK, Inc.'s Chief Strategy and Business Officer, explores the company's launch of R&D Cloud.

Actinogen Medical Limited (ASX: ACW) announces that the World Health Organization (WHO) has granted the nonproprietary name ...